Vivos (RDGL) Assets Growth (5y) (2015 - 2025)
Vivos (RDGL) Assets Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vivos | 24.08 Mn | 22.53 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.78% |
| Sep 30, 2025 | 108.75% |
| Jun 30, 2025 | 56.09% |
| Dec 31, 2024 | 119.46% |
| Sep 30, 2024 | 44.57% |
| Jun 30, 2024 | 105.50% |
| Mar 31, 2024 | 89.00% |
| Dec 31, 2023 | 150.01% |
| Sep 30, 2023 | 166.15% |
| Jun 30, 2023 | 193.90% |
| Mar 31, 2023 | 363.27% |
| Dec 31, 2022 | 156.50% |
| Sep 30, 2022 | 133.39% |
| Jun 30, 2022 | 24.07% |
| Mar 31, 2022 | 120.53% |
| Dec 31, 2021 | 107.98% |
| Sep 30, 2021 | 92.52% |
| Jun 30, 2021 | 95.98% |
| Mar 31, 2021 | 51.37% |
| Dec 31, 2020 | 29.82% |